HUTCHMED (China) (HCM) Non Operating Income (2018 - 2021)
HUTCHMED (China) (HCM) posted quarterly Non Operating Income of $3.0 million for Q2 2021, up 624.94% year-over-year from $413000.0 in Q2 2020, and up 921.84% quarter-over-quarter from $293000.0 in Q1 2021.
HUTCHMED (China) (HCM) Non Operating Income (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Non Operating Income for 4 consecutive years, with $3.0 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Non Operating Income rose 624.94% year-over-year to $3.0 million; the TTM figure through Jun 2021 stood at $4.9 million (up 54.37% YoY), while the FY2025 annual figure was $61.0 million, up 43.09% from the prior year.
- Non Operating Income rose to $3.0 million in Q2 2021 per HCM's latest filing, from $293000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $3.0 million in Q2 2021 and bottomed at -$31000.0 in Q4 2019.
- Historically, Non Operating Income has averaged $1.3 million across 4 years, with a median of $1.2 million in 2018.
- Annual changes were most pronounced in 2019 — Non Operating Income slumped 102.8% — and 2021, when it jumped 624.94%.
- HUTCHMED (China)'s Non Operating Income stood at $1.1 million in 2018, then plunged by 102.8% to -$31000.0 in 2019, then soared by 1432.26% to $413000.0 in 2020, then surged by 624.94% to $3.0 million in 2021.
- Business Quant data shows HCM's Non Operating Income at $3.0 million in Q2 2021, $293000.0 in Q1 2021, and $413000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | HUTCHMED (China) | 2.16 Bn | 2.16 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 2.99 Mn |
| Mar 31, 2021 | 293,000.00 |
| Jun 30, 2020 | 413,000.00 |
| Mar 31, 2020 | 1.17 Mn |
| Dec 31, 2019 | -31,000.00 |
| Sep 30, 2019 | 1.60 Mn |
| Jun 30, 2019 | 2.57 Mn |
| Mar 31, 2019 | 1.14 Mn |
| Dec 31, 2018 | 1.11 Mn |
| Sep 30, 2018 | 1.69 Mn |
| Jun 30, 2018 | 2.04 Mn |
| Mar 31, 2018 | 1.15 Mn |